Clinical Trials Browser

Neoplasms, Plasma Cell × isatuximab × 90 days × Clear all

NCT07600151 2026-05-20

CONQUISTADOR

Phase 1/2 Not yet recruiting

Multiple Myeloma, Neoplasms, Plasma Cell